Romofab Holding ApS: Financial statements 2024
CVR: 38556797
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Romofab Holding ApS (CVR 38556797) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK -2,029,900 compared with DKK -42,425 the year before. Equity in the 2024 report amounted to DKK -1,684,111.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK -2,029,900
- Equity
- DKK -1,684,111
- Total Assets
- DKK 2,914
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 0 | -2 mio. | -1.7 mio. | 0 |
| 2023 | - | -13 t. | -42 t. | 346 t. | 0 |
| 2022 | - | -13 t. | -29 t. | 388 t. | 0 |
| 2021 | - | -16 t. | -18 t. | 417 t. | 0 |
| 2020 | - | -15 t. | -18 t. | 436 t. | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Romofab Holding ApS has published its annual report for 2023. Gross profit came to DKK -13,125, and the net result was DKK -42,425.
About Romofab Holding ApS
Romofab Holding ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Molly Bilde Fabrin and Robert Fabrin. The company is owned by Robert Fabrin and Molly Bilde Fabrin. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -13,750 and a net result of DKK 284,766 compared with DKK -2,029,900 the year before. Equity in the 2025 report amounted to DKK -1,399,345.